Agenus to provide corporate update and third quarter 2025 financial report

Lexington, mass.--(business wire)---- $agen #botbal--agenus inc. (“agenus”) (nasdaq: agen), a leader in immuno-oncology, today announced that the company will release its third quarter 2025 financial results before the market opens on monday, november 10, 2025. the company also plans to host a stakeholder briefing webcast in late november to provide a corporate and clinical development update. additional details regarding the webcast will be announced in the coming weeks. about agenus agenus is a leading immuno-.
AGEN Ratings Summary
AGEN Quant Ranking